Comparison

SB220025 European Partner

Item no. TMO-T28681-50mg
Manufacturer TargetMol
CASRN 165806-53-1
Amount 50 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Smiles FC1=CC=C(C=C1)C=2N=CN(C2C=3N=C(N=CC3)N)C4CCNCC4
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias SB 220025,SB-220025
Shipping Condition Cool pack
Available
Manufacturer - Targets
p38 MAPK|||PKC
Storage Conditions
-20
Molecular Weight
338.38
Description
SB220025 is an orally available, selective and potent inhibitor of P38 mitogen-activated protein kinase that inhibits p56Lck and PKC, inhibits endothelial growth hormone-induced Ca(2+) signaling, and inhibits angiogenesis, and can be used in the study of arthritis.
Pathways
Chromatin/Epigenetic|||Cytoskeletal Signaling|||MAPK

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close